Background Advances in diagnostic and therapeutic strategies in oncology have
significantly increased the chance of survival of cancer patients, even those with metastatic …

Cancer-related cognitive impairment (CRCI) is a frequent side effect experienced by an
increasing number of cancer survivors with a significant impact on their quality of life …

Purpose Androgen deprivation therapy (ADT) may contribute to depression, yet several
studies have not demonstrated a link. We aimed to determine whether receipt of any ADT or …

Background There is increasing evidence that androgen deprivation therapy (ADT) may be
associated with depression. Existing studies have shown conflicting results. Methods …

Background: Androgen deprivation therapy (ADT) to treat prostate cancer may be
associated with an increased risk of dementia, but existing studies have shown conflicting …

Purpose: Despite the effectiveness of androgen deprivation therapy in advanced prostate
cancer, serious neuropsychiatric consequences in androgen deprivation therapy (ADT) …

Purpose To assess the relative risk of Alzheimer's disease (AD) among patients with
prostate cancer who received androgen deprivation therapy (ADT), after adjustment for other …

Objectives To review the proposed mechanisms of cognitive changes associated with non-
central nervous system cancers and cancer treatment. Data Sources Review and synthesis …

Objectives To examine whether any androgen deprivation therapy use or longer duration is
associated with an increased risk of anxiety in patients with prostate cancer. Methods We …

The aim of this prospective multi‐centre study was to evaluate the level of psychological
distress (PD) and adjustment to disease in patients who underwent radical prostatectomy …